Standard Operating Procedure for Market Entry Readiness Review Before Filing
| Department | Regulatory Affairs |
| SOP No. | RA/2026/646 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the systematic process for conducting a comprehensive Market Entry Readiness Review prior to filing regulatory submissions. It ensures that all necessary regulatory, quality, and operational requirements are met, documents are complete and compliant, and the product is adequately prepared for successful market authorization. The control objective is to minimize risks of submission rejections or delays by verifying readiness across all critical areas before filing.
Scope
This SOP applies to all regulatory affairs activities involved in preparing product dossiers and filings for market authorization. It covers all dosage forms, therapeutic products, and related documentation intended for submission across any regulated market. The scope includes cross-functional coordination with departments such as Quality Assurance, Quality Control, Manufacturing, and Technical Operations to verify completeness and compliance. This SOP excludes activities related to post-approval changes or ongoing regulatory maintenance.
Responsibilities
- Regulatory Affairs Team: Responsible for coordinating the readiness review, compiling dossier documents, and ensuring compliance with regulatory requirements.
- Quality Assurance: Reviews quality-related documents, batch records, validation summaries, and ensures GMP compliance.
- Quality Control: Provides analytical data and certificates of analysis required for submission.
- Manufacturing and Technical Operations: Confirms manufacturing readiness and validation status.
- Regulatory Affairs Head: Supervises the overall process and approves the final readiness confirmation prior to submission.
Accountability
The Regulatory Affairs Head is accountable for ensuring the Market Entry Readiness Review is thoroughly conducted as per this SOP. This role is responsible for implementation, compliance monitoring, escalation of issues, periodic review of effectiveness, and ensuring that corrective actions are taken if gaps are identified.
Procedure
The Market Entry Readiness Review is conducted in the following stages:
1. Preparation and Planning: Define the timeline and scope for the readiness review aligned with filing schedules. Identify cross-functional team members involved in the review. Gather all relevant documents including the product dossier, quality data, validation reports, and regulatory checklists.
2. Prerequisites and Safety Checks: Confirm that all prerequisite activities, such as process validation, equipment qualification, and stability studies, have been completed and approved. Verify that Good Manufacturing Practice (GMP) and Good Documentation Practice (GDP) standards are followed throughout all documentation.
3. Document Verification: Conduct a thorough review of all submission documents. Check for completeness, accuracy, consistency, and adherence to regulatory guidelines. Areas of focus include product specifications, manufacturing processes, batch analysis, stability data, risk assessments, and labeling.
4. Cross-Functional Validation: Engage QA, QC, and Manufacturing teams to confirm that all required reports and certifications are finalized and approved. Validate analytical methods and ensure their suitability for release testing. Confirm that manufacturing sites and equipment are qualified and compliant.
5. Review Meeting and Gap Analysis: Organize a formal review meeting with all stakeholders. Present findings, highlight any gaps or non-conformances, and develop corrective action plans where necessary. Establish clear timelines for resolution.
6. Approvals and Sign-Off: Once all gaps are addressed, obtain documented approvals from department heads and the Regulatory Affairs Head confirming readiness for filing.
7. Documentation and Record Retention: Compile the readiness review checklist, meeting minutes, approval forms, and supporting documents into a dedicated filing system. Ensure all records are maintained as per internal retention policies and compliance standards.
8. Closure: Communicate the readiness status to relevant teams and proceed with submission as scheduled. Monitor for any feedback or post-filing queries requiring further attention.
This procedure ensures a standardized, thorough, and compliant approach to market entry readiness that mitigates risks and supports successful regulatory submissions.
Abbreviations
- GMP – Good Manufacturing Practice
- GDP – Good Documentation Practice
- QA – Quality Assurance
- QC – Quality Control
- RA – Regulatory Affairs
- CAPA – Corrective and Preventive Action
- SOP – Standard Operating Procedure
Documents
- Market Entry Readiness Review Checklist (Annexure-1)
- Market Entry Review Meeting Minutes (Annexure-2)
- Approval Form for Market Entry Readiness (Annexure-3)
References
- ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
- EU Guidelines for Good Manufacturing Practice for Medicinal Products
- FDA Guidance for Industry – Submission of Documentation for Market Authorization
- Company Quality Management System Documentation
- Regulatory Authority Submission Requirements and Templates
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Market Entry Readiness Review Checklist
| Section | Item | Status (Yes/No/NA) | Comments |
|---|---|---|---|
| Documentation | Complete Product Dossier Prepared | Yes | All sections compiled |
| Quality | Batch Release Certificates Available | Yes | Latest batch released 01/03/2026 |
| Quality | Validation Reports Approved | Yes | Process & Analytical validations done |
| Manufacturing | Equipment Qualification Completed | Yes | Qualification documents reviewed |
| Regulatory | Labeling Complies with Regulation | Yes | Label drafts approved 05/04/2026 |
| Stability | Stability Data Meets Requirements | Yes | 12-month stability data available |
| Compliance | GMP Audits Completed | Yes | Last audit 15/02/2026 |
| Review | Readiness Review Meeting Conducted | Yes | Meeting on 07/04/2026 |
| Approvals | All Approvals Obtained | Yes | Signed off by all departments |
Annexure-2: Market Entry Review Meeting Minutes
| Meeting Date | 07/04/2026 |
|---|---|
| Location | Conference Room B |
| Attendees | Regulatory Affairs, QA, QC, Manufacturing Representatives |
| Agenda | Review of readiness status prior to filing |
| Discussion Points |
|
| Actions | Approval forms to be signed by 09/04/2026 |
| Next Steps | Proceed with submission as scheduled |
Annexure-3: Approval Form for Market Entry Readiness
| Product Name | ______________ |
|---|---|
| Filing Reference | ______________ |
| Department | Regulatory Affairs |
| Date | 09/04/2026 |
| Approvals | Signature / Date |
| Regulatory Affairs Head | _____________________ / __/__/____ |
| Quality Assurance Head | _____________________ / __/__/____ |
| Quality Control Head | _____________________ / __/__/____ |
| Manufacturing Head | _____________________ / __/__/____ |
| Comments | ______________________________________________________________________________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |